Synchrony Financial (SYF)
NYSE: SYF · Real-Time Price · USD
67.53
-2.14 (-3.07%)
At close: Aug 1, 2025, 4:00 PM
67.50
-0.03 (-0.04%)
After-hours: Aug 1, 2025, 7:46 PM EDT

Theseus Pharmaceuticals Revenue

Synchrony Financial had revenue of $2.50B in the quarter ending June 30, 2025, with 23.75% growth. This brings the company's revenue in the last twelve months to $9.19B, up 4.65% year-over-year. In the year 2024, Synchrony Financial had annual revenue of $9.39B with 22.58% growth.

Revenue (ttm)
$9.19B
Revenue Growth
+4.65%
P/S Ratio
2.84
Revenue / Employee
$459,250
Employees
20,000
Market Cap
25.13B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20249.39B1.73B22.58%
Dec 31, 20237.66B-637.00M-7.68%
Dec 31, 20228.30B-1.17B-12.33%
Dec 31, 20219.47B3.61B61.76%
Dec 31, 20205.85B-3.28B-35.92%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.